Compare SPDR Gold Trust (GLD) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Invesco Ltd. — how do they compare? SPDR Gold Trust trades at $384.4 (market cap $139.66B), while Invesco Ltd. trades at $29.52 (market cap $13.28B). The key difference: SPDR Gold Trust is far larger — about 10.5× Invesco Ltd.'s market cap, and Invesco Ltd. pays a 2.86% dividend while SPDR Gold Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Invesco Ltd. for 77 Days on average.
| GLD | IVZ | |
|---|---|---|
Market Cap | $139.66B | $13.28B |
Volume | 9,544,773 | 3,698,033 |
52-Week High | $495.90 | $33.31 |
52-Week Low | $362.32 | $22.44 |
Typical Hold Time | 74 Days | 77 Days |
Sector | — | Financials |
Enterprise Value | — | $23.45B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD trades at $384.58, up 2.31% with bearish technical signals dominating. The ETF faces pressure from rising Treasury yields and a strong dollar, with technical indicators showing 17 sell signals versus 2 buy signals. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with prices testing key support levels amid Federal Reserve policy uncertainty.
The outlook remains cautious as elevated yields and dollar strength create headwinds, though some analysts see tactical opportunities near current levels. Key risks include further Fed tightening and bond market volatility, while potential catalysts include geopolitical tensions and inflation concerns. The technical setup suggests continued pressure with support at $377-$374.
Invesco (IVZ) trades at $29.51, down 3.25% today, with bearish technical signals dominating. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026, while Q3 2026 results are pending. Despite negative net income margins in 2025, operating cash flow remains strong at $1.53 billion, and analyst consensus leans toward Hold with a $33.71 price target. Recent news highlights ETF expansions and AUM growth to $2.56 trillion in August 2026.
The outlook is cautious; IVZ faces profitability challenges with negative ROE and net margins, but solid cash flow and analyst buy ratings (42.86%) suggest recovery potential. Risks include earnings volatility and competitive ETF pressures, while institutional sentiment is neutral. The stock's current price near the low end of analyst targets ($28-$41) may appeal to value investors betting on operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
